Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

24.48
Delayed Data
As of Jun 27
 -0.76 / -3.01%
Today’s Change
23.85
Today|||52-Week Range
43.63
-42.78%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Cohen Ronald
President & Chief Executive Officer
Sale10/02/2015134,090$28.01$3.8M-12.73%
Lawrence David /acorda/
Sale12/18/201538,506$40.62$1.6M-39.88%
Blight Andrew R
Chief Scientific Officer
Sale10/19/201528,800$30.82$887.6K-21.03%
Cohen Ronald
President & Chief Executive Officer
Buy10/02/201554,421$15.49$843.0K-12.73%
Sabella Lauren M
Chief Commercial Officer
Sale12/17/201514,229$40.00$569.2K-39.42%
Smith Ian F
Director
Sale1/04/201613,131$41.85$549.5K-42.06%
Wasman Jane
President-International & General Counsel
Sale12/23/201510,751$43.10$463.4K-43.00%
Cohen Ronald
President & Chief Executive Officer
Sale12/01/201511,850$38.08$451.2K-35.34%
Cohen Ronald
President & Chief Executive Officer
Buy10/02/201570,358$5.85$411.6K-12.73%
Wasman Jane
President-International & General Counsel
Sale12/22/20158,455$42.07$355.7K-43.04%
Page of 7